Search
-
News
Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.
… Friday, May 1, 2009 Summary Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards. Joan Massagué , Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute , has been named the
-
Information about admission requirements, application procedure, and information about our entrance examination.
… Applicants must be at least 18 years of age and possess a minimum of an Associate’s Degree from an accredited college and a minimum average GPA of 2.5, overall from all schools attended. In addition, all applicants must have completed at least one full-semester of each a college level math course (applied
-
News
Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients.
… Wednesday, April 19, 2023 At a worldwide gathering of the American Association for Cancer Research (AACR), Memorial Sloan Kettering Cancer Center (MSK) scientists presented new insights into the connection between cancer and the gut microbiome, often referred to as the “forgotten organ.” Their findings
-
Learn about a blood condition called clonal hematopoiesis (CH) and Memorial Sloan Kettering’s CH clinic.
… Clonal hematopoiesis (CH) happens when a cell called a hematopoietic stem cell, which can develop into different types of blood cells, starts making cells with the same genetic mutation. These blood cells have a different genetic pattern than the rest of your blood cells. There are no warning signs of
-
Obtenga más información sobre una afección sanguínea llamada hematopoyesis clonal (CH) y sobre la clínica de CH del Memorial Sloan Kettering.
… La hematopoyesis clonal (CH) ocurre cuando una célula llamada célula madre hematopoyética, que puede convertirse en diferentes tipos de células sanguíneas, comienza a producir células con la misma mutación genética. Estas células sanguíneas tienen un patrón genético diferente al del resto de las células
-
The Scott Keeney Lab
… Job Title Research Fellow Degree PhD Email [email protected] Lab Phone 212-639-5180
-
The replacement has been lengthened 72.4 mm (2 7/8 in) to keep up with growth in a teenaged boy who was cured of his osteosarcoma. The device was secured in the femur (thighbone) without cement, relying on the boy's own bone to grow into the device
… Expandable Knee Replacement The replacement has been lengthened 72.4 mm (2 7/8 in) to keep up with growth in a teenaged boy who was cured of his osteosarcoma. The device was secured in the femur (thighbone) without cement, relying on the boy’s own bone to grow into the device.
-
Insurance resources specifically for cancer survivors
… People who have had cancer can still qualify for life insurance; however, it will likely be more difficult. Acquiring coverage often depends on the specific insurance company, each of which has different requirements based on the type of cancer you had or how long you have been out of treatment. Some
-
Patient & Caregiver Education
This information explains what to expect after you complete your prostate radiation.
… This information explains what to expect after you complete your prostate radiation. Follow-up Appointments After you finish your radiation therapy, you will have follow-up appointments. Your visits will be with your doctor or advanced practice provider (APP). An APP is a healthcare provider with special
-
Patient & Caregiver Education
En esta información se explica qué esperar después de terminar su radioterapia de próstata.
… En esta información se explica qué esperar después de terminar su radioterapia de próstata. Citas de seguimiento Una vez que termine su radioterapia, tendrá citas de seguimiento. Su médico de cabecera o su proveedor de práctica avanzada (APP) le atenderán en estas visitas. Un APP es un proveedor de cuidados